Is endothelial cell autocrine production of tumor necrosis factor a mediator of lipid-induced endothelial dysfunction?

Medical Hypotheses

Volumn 47, Issue 5, 1996, Pages 377-382

  Toborek, M ^a   Hennig, B ^b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; LINOLEIC ACID; LIPID; LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROSIS; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HUMAN; HYPOTHESIS; INFLAMMATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

EID: 0029796669     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(96)90217-0     Document Type: Article

References (49)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
2. Berliner J A, Navab M, Fogelman A M et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 1995; 91: 2488-2496.
3. Albelda S M, Smith C W, Ward P A. Adhesion molecules and inflammatory injury. FASEB J 1994; 8: 504-512.
4. Hennig B, Toborek M, Cader A A, Decker E A. Nutrition, endothelial cell metabolism, and atherosclerosis. Crit Rev Food Sci Nutr 1994; 34: 253-282.
5. Zilversmit D B. A proposal linking atherogenesis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res 1973; 33: 633-638.
6. Zilversmit D B. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473-485.
7. Hennig B, Alvarado A, Ramasamy S, Boissonneault G A, Decker E A, Means W J. Fatty acid-induced disruption of endothelial barrier function in culture. Biochem Arch 1990; 6: 409-417.
8. Spector A A, Kaduce T L, Hoak J C, Fry G L. Utilization of arachidonic and linoleic acids by cultured endothelial cells. J Clin Invest 1981; 68: 1003-1011.
9. Hennig B, Watkins B A. Linoleic acid and linolenic acid: effect on permeability properties of cultured endothelial cell monolayers. Am J Clin Nutr 1989; 49: 301-305.
10. Cader A A, Butterfield D A, Watkins B A, Chung B H, Hennig B. Electron spin resonance studies of fatty acid-induced alterations in membrane fluidity in cultured endothelial cells. Int J Biochem Cell Biol 1995; 27: 665-673.
11. Ramasamy S, Boissonneault G A, Decker E A, Hennig B. Linoleic acid-induced endothelial cell injury: role of membrane-bound enzyme activities and lipid oxidation. J Biochem Toxicol 1991; 6: 29-35.
12. Steinberg D, Parthasarathy S, Carew T E, Khoo J C, Witztum J L. Beyond cholesterol: modification of low density lipoprotein that increases its atherogenicity. N Engl J Med 1989; 320: 915-924.
13. Steinbrecher U P, Parthasarthy S, Leake D S, Witztum J L, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984; 81: 3883-3887.
14. Morel D W, DiCorleto P E, Chisholm G M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984; 4: 357-364.
15. Navab M, Imes S S, Hama S Y et al. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 1991; 88: 2039-2046.
16. Rajavashisth T B, Andalibi A, Territo M C et al. Induction of endothelial cell expression of granulocyte and macrophage colony stimulating factors by modified low density lipoprotein. Nature 1990; 244: 254-257.
17. Kugiyama K, Kerns S A, Morrisett J D, Roberts R, Henry P D. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low density lipoproteins. Nature 1990; 344: 160-162.
18. Berliner J A, Territo M C, Sevanian A et al. Minimally modified LDL stimulates monocyte endothelial interaction. J Clin Invest 1990; 85: 1260-1266.
19. Tracey K J, Cerami A. Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels. Proc Soc Exp Biol Med 1992; 200: 233-239.
20. Cendan J C, Moldawer L L, Souba W W, Copeland E M, Lind S. Endotoxin-induced nitric oxide production in pulmonary artery endothelial cells is regulated by cytokines. Arch Surg 1994; 129: 1296-1300.
21. Kahaleh M B, Zhou S. Induction of tumor necrosis factor (TNF) synthesis by endothelial cells upon exposure to r-TNF. Arthritis Rheum 1989; 32: S124.
22. Nagura H, Ohtani H. Expression of major histocompatibility class-II antigens by vascular endothelial cells leads to amplified immunoinflammatory processes. Acta Histochem Cytochem 1992; 25: 653-660.
23. Schreck R, Albermann K, Baeuerle P A. Nuclear factor κB: an oxidative stress responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 1992; 17: 221-237.
24. Parhami F, Fang Z T, Fogelman A M, Andalibi A, Territo M C, Berliner J A. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 1993; 92: 471-478.
25. Toborek M, Barve S, McClain C J et al. Linoleic acid potentiates TNF-mediated endothelial cell dysfunction. FASEB J 1995; 9: A322.
26. Toborek M, Barger S W, Mattson M P, Barve S, McClain C J, Hennig B. Linoleic acid and TNF-α cross-amplify oxidative injury and dysfunction of endothelial cells. J Lipid Res 1996; 37: 123-135.
27. Hennig B, Toborek M, Joshi-Barve S et al. Linoleic acid activates NF-κB and induces NF-κB dependent transcription in cultured endothelial cells. Am J Clin Nutr 1996; 63: 322-328.
28. Read M A, Whitley M Z, Williams A J, Collins T. NF-κB and IκBα: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503-512.
29. Thanos D, Maniatis T. NF-κB: A lesson in family values. Cell 1995; 80: 529-532.
30. Collins T. Endothelial nuclear factor-κB and the initiation of the atherosclerotic lesion. Lab Invest 1993; 68: 499-508.
31. Shirakawa F, Mizel SB. In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol 1989; 9: 2424-2430.
32. Toborek M, Hennig B. Fatty acid-mediated effects on the glutathione redox cycle in cultured endothelial cells. Am J Clin Nutr 1994; 59: 60-65.
33. Droge W, Schulze-Osthoff K, Mihm S et al. Functions of glutathione disulfide in immunology and immunopathology. FASEB J 1994; 8: 1131-1138.
34. Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-κB. Annu Rev Cell Biol 1994; 10: 405-455.
35. Paleolog E M, Delasalle S-A J, Burman W A, Feldman M. Functional activities of receptors for tumor necrosis factor-α on human vascular endothelial cells. Blood 1994; 84: 2578-2590.
36. Slowik M R, de Luca L G, Fiers W, Pober J S. Tumor necrosis factor activates human endothelial cells through the p55 tumor necrosis factor receptor but the p75 receptor contributes to activation at low tumor necrosis factor concentration. Am J Pathol 1993; 143: 1724-1730.
37. Bradley J R, Thiru S, Pober J S. Disparate localization of 55-kd and 75-kd tumor necrosis factor receptors in human endothelial cells. Am J Pathol 1995; 146: 27-32.
38. Collins T, Read M A, Neish A S, Whitley M Z, Thanos D, Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995; 9: 899-909.
39. Read M A, Neish A S, Luscinskas F W, Palombella V J, Maniatis T, Collins T. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 1995; 2: 493-506.
40. Toborek M, Barger S W, Mattson M P, McClain C J, Hennig B. Role of glutathione redox cycle in TNF-mediated endothelial cell dysfunction. Atherosclerosis 1995; 117: 179-188.
41. Koga S, Morris S, Ogawa S et al. TNF modulates endothelial properties by decreasing cAMP. Am J Pathol 1995; 268: C1104-1113.
42. Hanemaaijer R, Koolwijk P, le Clercq L, de Vree W J, van Hinsbergh V W. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 1993; 296: 803-809.
43. Toborek M, Hennig B. Vitamin E attenuates induction of elastase-like activity by tumor necrosis factor-α, cholestan-3β,5α,6β-triol, and linoleic acid in cultured endothelial cells. Clin Chim Acta 1993; 215: 201-211.
44. Polunovsky V A, Wendt C H, Ingbar D H, Peterson M S, Bitterman P B. Induction of endothelial cell apoptosis by TNF alfa: modulation by inhibitors of protein synthesis. Exp Cell Res 1994; 214: 584-594.
45. Rus H G, Niculescu F, Vlaicu R. Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 1991; 89: 247-254.
46. Barath P, Fishbein M C, Cao J, Berenson J, Helfant R H, Forrester J S. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65: 297-302.
47. Wong G H. Protective roles of cytokines against radiation: induction of mitochondrial MnSOD. Biochim Biophys Acta 1995; 1271: 205-209.
48. Ramasamy S, Lipke D W, McClain C J, Hennig B. Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells. J Cell Physiol 1995; 162: 119-126.
49. Ramasamy S, Boissonneault G A, Lipke D W, Hennig B. Proteoglycans and endothelial barrier function: effect of linoleic acid exposure to porcine pulmonary artery endothelial cells. Atherosclerosis 1993; 103: 279-290.